Ronald J. Shebuski

Principal investigator.

Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2023First federal award
$3.3MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Career record

Federal awards and patents by year

20232026
AwardsPatents
Federal awards as principal investigator

8 awards · $3.3M

DateAgencyAwardAmountCompany
Jul 22, 2026NIHSBIR Phase I
Engineering Nitric Oxide Releasing Intravascular Catheters with Solid Slippery Surfaces to Combat Infection and Thrombosis
$314KNYTRICX INC
Aug 30, 2024NIHSTTR Phase I
Enhanced Prosthetic Vascular Graft Function by Local Release of Nitric Oxide
$312KNYTRICX INC
Jul 18, 2024NIHSTTR Phase II
Ultra-low Fouling and Anti-infective and Anti-thrombotic Nitric Oxide Releasing Intravascular Catheters
$121KNYTRICX INC
Jul 17, 2024NIHSTTR Phase II
Ultra-low Fouling and Anti-infective and Anti-thrombotic Nitric Oxide Releasing Intravascular Catheters
$876KNYTRICX INC
Apr 19, 2024NIHSTTR Phase II
Ultra-low Fouling and Anti-infective and Anti-thrombotic Nitric Oxide Releasing Intravascular Catheters
$50KNYTRICX INC
Jan 15, 2024NIHSTTR Phase II
Ultra-low Fouling and Anti-infective and Anti-thrombotic Nitric Oxide Releasing Intravascular Catheters
$106KNYTRICX INC
Sep 14, 2023NIHSTTR Phase II
Ultra-low Fouling and Anti-infective and Anti-thrombotic Nitric Oxide Releasing Intravascular Catheters
$1.2MNYTRICX INC
Jul 11, 2023NIHSBIR Phase I
Nitric oxide Releasing Ultra-Slippery Antibacterial Surfaces for Urological Catheter Applications
$337KNYTRICX INC
Among 4,795 researchers in Medtech

Peer ranks

Federal funding#565
Awards as PI#216
Patents#505
From filings, awards and patents

Companies

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.